$SGRY

Surgery Partners, Inc. (SGRY): Submission of Matters to a Vote of Security Holders

Surgery Partners, Inc. (SGRY) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. sgry-20260605 0001638833 FALSE 0001638833 2026-06-05 2026-06-05 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported):

Original reporting
Published Jun 5, 2026, 8:50 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 9, 2026, 8:46 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$SGRY
Neutral
medium confidence
Mentioned
$SGRY
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$SGRYNeutralLow
01

Why it matters

This is a governance/proxy disclosure (director elections, advisory executive compensation, and auditor ratification) with no stated operational or financial changes.

02

Market read

Primarily relevant for governance-focused positioning; not a fundamental catalyst for trading.

03

What to watch

Traders may overreact to proxy mechanics; without accompanying changes (CEO/CFO, strategy, financing, litigation), the impact is typically limited.

Relevance 6/10Novelty 3/10Timing: after-hours / filed June 5, 2026

Background

The company held its annual meeting on June 5, 2026; the 8-K reports the final voting results for three proposals.

Company-level read

Ticker impact

$SGRYNeutralMedium confidence
Context

Surgery Partners filed an 8-K reporting final results of its June 5, 2026 annual meeting votes, including director elections and say-on-pay.

Expected impact

Low near-term impact; any reaction is likely limited to governance/proxy sentiment rather than fundamentals.

Evidence & confidence

The disclosure is procedural (8-K Item 5.07) and provides vote tallies without changes to strategy, earnings, contracts, or regulatory status.

Market effects

Minimal; governance vote results do not reset sector fundamentals.

None indicated.

None indicated.

Counterpoint

If the vote tallies show unusually high opposition/withheld votes, it could hint at governance dissatisfaction that may matter for longer-horizon investors, but the filing still lacks a direct catalyst.

Key entities

  • Surgery Partners, Inc.

    Nasdaq-listed company filing Item 5.07 results from its annual meeting votes.

  • Ernst & Young LLP

    Ratified as independent registered public accounting firm for fiscal year 2026.

Related articles

$SGRYMed

Why Is Surgery Partners Stock Gaining Friday? - Surgery Partners (NASDAQ:SGRY)

Surgery Partners (SGRY) said it will sell its ownership interests in Mountain View Hospital and Idaho Falls Community Hospital to Intermountain Health for about $795 million, valuing the facilities at roughly $1.15 billion, subject to physician partner approval. The company reaffirmed fiscal 2026 revenue of $3.35 billion to $3.45 billion and adjusted EBITDA of at least $530 million.

$SGRYMedAI 8/10

Surgery Partners jumps on $1.15B hospital sale deal By Investing.com

Surgery Partners (NASDAQ:SGRY) rose 5.8% after agreeing to sell two Idaho Falls hospitals to Intermountain Health for about $1.15B. Surgery Partners expects about $795M for its ownership interests, with cash proceeds subject to purchase price adjustments. The deal needs approvals and regulatory steps and is expected to close in coming months. 2026 outlook was reaffirmed excluding the deal.

$SGRYMedAI 8/10

Surgery Partners To Sell 2 Idaho Hospitals To Intermountain For $795 Mln, Backs FY View; Shares Jump

Surgery Partners (SGRY) said it signed agreements to sell its interests in Mountain View Hospital and Idaho Falls Community Hospital in Idaho to Intermountain Health for about $795 million. The hospitals were valued around $1.15 billion. Surgery Partners reaffirmed its FY2026 revenue of $3.35B to $3.45B and adjusted EBITDA of at least $530M excluding the deal. Shares rose to about $16.51.

$SGRYMed

Why Surgery Partners (SGRY) Stock Is Trading Up Today

Surgery Partners (SGRY) shares rose about 2.7% in the morning to around $17.15 after Cantor Fitzgerald reiterated an “Overweight” rating and set an $18.00 price target. Cantor cited some softness in Q2 ambulatory surgery center and outpatient nursing data, but kept a positive view. Other analysts expect profitability this year.

SK Hynix said to mull options for US$3 billion Chongqing plant

SK Hynix is considering options for its Chongqing, China semiconductor packaging and testing facility, including possibly bringing in an investor to accelerate growth. People familiar said a potential stake sale could value the plant at about US$3 billion and SK Hynix may keep a minority stake. Separately, it plans a 54 trillion won (US$38 billion) South Korea expansion for DRAM and NAND.